Urologist, head of urology, Kantonsspital Winterthur, MPH, EAU testis cancer guideline panel, ERAS cystectomy panel, SAKK GU core group
Winterthur, Switzerland
Joined July 2020
- Tweets498
- Following555
- Followers1K
- Likes1.8K
Christian D. Fankhauser retweeted
My son’s Jones Beach IRONMAN was canceled this morning, so I built something I’ve wanted for a while: one place for daily urology news, events & podcasts.
Introducing UrologyWatch.com.
Tell me what works, what doesn’t, and whether it’s worth maintaining.
🤖 Made with AI
New video: I changed my surgical technique this month after learning from an old case. I now always do primary bladder neck closure with an omental flap and a suprapubic catheter, in addition to the Mitrofanoff/Monti stoma catheter youtu.be/2HpYYqorjkg
🎥In my new job as head of dept I’m launching a youtube video channel
🏆 Europe’s first SP RPLND – Video Prize winner at @ERUSrobotics
IMHO SP offers a more favorable instrument angle + fully hidden ports below the underwear line
▶️ youtu.be/ShwGvynqsg8?is=srD4…
Christian D. Fankhauser retweeted
This is one of the best pieces I’ve read in a long time. Many thanks to @anish_koka for this superb piece and thoughtful recounting. Those who really know @VPrasadMDMPH know he will do even more good and rise even higher.
Christian D. Fankhauser retweeted
Our @JCO_ASCO commentary is out today:
“BCG and Beyond: Is Systemic Immunotherapy for BCG-Naïve NMIBC Progress or Overreach?”
Systemic IO has now entered the BCG-naïve high-risk NMIBC space. The signal is real. The interpretation must be disciplined.
Thread below. 🧵
#BladderCancer #GU26 #EAU26 @AndreaNecchi @BrigidaMaiorano @shilpaonc @UrogerliMD @pjhensley11 @spsutkaMD @AmirHorowitz @IBCG_BladderCA @JCO_ASCO #OncSurgery
Christian D. Fankhauser retweeted
in J Urol this month a decision analysis of PLND during RP
Take home message: benefits of PLND outweigh risk for most patients.
auajournals.org/doi/10.1097/…
@VickersBiostats @UrologyMSK #prostatecancer
@Uroweb @AmerUrological
Christian D. Fankhauser retweeted
It's out 🚀 Our multicentric collaboration just got published in @BJUIjournal. Huge thanks to all our incredible co-authors and the @YAUpenile_tesCa who made this work possible.
Read it here: bjui-journals.onlinelibrary.…
@MaartenAlbersen, @Brouwer_MD_PhD, @BE_Ayres, @CDFankhauser
Christian D. Fankhauser retweeted
New out in @TheLancetOncol with Ted Schaeffer:
pubmed.ncbi.nlm.nih.gov/4103…
"Revisiting prostate cancer active surveillance candidacy"
A close look at the fallacy and risks of active surveillance (AS) in unselected intermediate risk (IR) men.
@wandering_gu @TylerSbrt
Christian D. Fankhauser retweeted
Ever wondered whether elective scrotal surgery really needs perioperative antibiotic prophylaxis (PAP)? 🤔
Our new @wjurol study found a 3× lower SSI rate (12% vs 4%; p=0.058) and fewer readmissions (26% vs 16%; p=0.13) with PAP.
Although not statistically significant, PAP may still help protect selected high-risk patients from postoperative infections.
In an era of rising antimicrobial resistance, routine prophylaxis warrants careful reconsideration! 💊
🔗 Full text – rdcu.be/eIo6F
@MaximeValle5 @StanglFabian @endouro @AgostinoMattei @CDFankhauser
Christian D. Fankhauser retweeted
Would surgery add survival benefit to the systemic treatment in patients with oligometastatic prostate cancer ? A new data highlights this;
👉Adding radical prostatectomy to best systemic therapy cut 5-yr cancer-specific mortality from 23% to 13% (HR 0.39, p=0.045). Early termination of study, OS benefit not statistically significant; 14% had major surgery complications.
👉Supports further efforts for local therapy + systemic treatment in oligomet prostate cancer.
doi.org/10.1016/j.eururo.202…
@EUplatinum @OncoAlert @ONCOassist @APCCC_Lugano
Christian D. Fankhauser retweeted
Still leading the pack! @EUplatinum
European Urology remains at the top of our field in Nephrology and Urology!
With the new IF of 25.2, over 2 million website downloads, and 40.7k followers on Twitter we are constantly striving to be a cut above the rest!
Thank you to our Authors, Reviewers, and Readership!
#impactfactor #UroSoMe #MedTwitter
Christian D. Fankhauser retweeted
@JoshMeeks provides an amazing overview of the significant data emerging in the BCG-unresponsive NMIBC space, focusing on the CIS cohorts. We also discuss the recent ODAC decision on UGN-102 for lower risk disease which was recently FDA approved.
spotifycreators-web.app.link…
ALT Data from the CIS Cohorts of BCG-unresponsive NMIBC trials
Christian D. Fankhauser retweeted
It's #BladderCancerAwarenessMonth! Urologists play a key role in smoking cessation counseling. Tune in as @CDFankhauser and Dr. Richard Matulewicz @MSKCancerCenter discuss #URO54
open.spotify.com/episode/1LU…
Christian D. Fankhauser retweeted
Thanks @Cacciamani_MD 🙏
⚡️ Use AI to boost your practice! This video covers 11 immediate applications, from AI scribes to virtual assistants
Here's a bonus quote from @CanesDavid, an outstaying colleague and one of my source of inspiration.. (for real!!)
"If you're entering patient information though, you want to remember to use a HIPAA-compliant interface like Doximity GPT, which is free." ()
#AIinMedicine #MedicalTechnology #Efficiency #AUA2025 #ArtificialIntelligence #Healthcare #Telehealth
#PhysicianLife
youtu.be/OJLqIU2nbzc?si=mmSp…
Christian D. Fankhauser retweeted
New results from the CREST Study (NCT04165317) for HR-NMIBC:
Adding sasanlimab to BCG induction + maintenance shows:
•32% ⬇️of EFS event (HR 0.68, p=0.0095)
•>50% reduction in HG recurrence
•No difference in overall survival (OS interim HR 1.13, p=0.6791) #AUA25 #bladdercancer
Christian D. Fankhauser retweeted
More great data from Alberta: @urethrologist present long-term urinary toxicity following various tx combinations for #prostatecancer RP seems to do the best, but none of these curves flattens over time. #aua25
Christian D. Fankhauser retweeted
Nobel laureate Bill Kaelin on Killing the Science Golden Goose.
"This is especially worrisome because becoming a scientist is largely taught by apprenticeship, with each generation teaching the next. We risk losing the next generation, our “seed corn”"
amjmed.com/article/S0002-934…
Great topic and speaker
❓ Role of SBRT-only in hormone-sensitive oligometastatic prostate cancer
❓ Value of 6-months ADT added to SBRT
❓ Appropriate endpoints
Virtual Grand Rounds in Radiation Oncology
usz.ch/en/events/virtual-gra…
Proudly presenting: @BarbaraJereczek
Wed April 2nd 17:00 – 17:30 CET 👇
Christian D. Fankhauser retweeted
Tired of the noise on @X? Join our @telegram channel w/all the key European Urology Network updates and important #urology pubs in one place. No Elon musk tweets or ads just pubs and your own community. Subscribe info below 👇 @Uroweb @AmerUrological #AcademicResearch – at United States